Patients with peripheral arterial disease (PAD) are at increased risk for stroke, myocardial infarction (MI) and cardiovascular death. Prior studies have focused on the prevalence of PAD, but the rate of ischaemic outcomes among a diverse group of patients with PAD has received less attention. In addition, the assessment of ischaemic outcomes with the use of a survey in place of casenote review, to our knowledge, has not been defined. The purpose of this pilot study was to develop an ischaemic outcomes survey that could be used in place of the labour-intensive casenote review, for data collection as part of a large epidemiological study.
Methods
A data abstraction form was used as a guide in blinded casenote reviews to compare the patient's reported medical history to casenote documented ischaemic events. The proportion agreement and Cohen's kappa were used to measure the agreement and the statistical significance of this agreement between the questionnaire and casenote review items. Fifty-one patients with a history of PAD were consented and interviewed using a 23-item questionnaire that focused on the ischaemic events of unstable angina, MI, cerebral vascular accident, transient ischaemic attacks, lower extremity revascularisation, or lower extremity amputation.
Results
Of the 23 patient survey items, proportion agreement was ≥ 70% on more than half of the items with kappa statistics that were fair-to-moderate. For ischaemic outcomes such as lower extremity bypass surgery, there were no yes responses from the patient or within the medical record, which reflects the low prevalence of this outcome.
Conclusions
Overall, the ischaemic outcomes questionnaire was a valid research tool. It yielded statistically significant kappa values on several items. Although additional work is needed, the present survey provides a good framework on which to develop the final questionnaire, which will be used in a large prospective cohort study to capture ischaemic events in patients with PAD.
McDermott MMAnkle brachial index as a predictor of outcomes in peripheral arterial disease. J Lab Clin Med1999;133:33-40.
2.
Collins TC, Petersen NJ, Suarez-Almazor M., Ashton CMThe prevalence of peripheral arterial disease in a racially diverse population . Arch Intern Med2003;163:1469-74.
3.
Meijer WT, Hoes AW, Rutgers D. et al. Peripheral arterial disease in the elderly, the Rotterdam study . Arterioscler Thromb Vasc Biol1998;18: 185-92.
4.
Weitz JI, Byrne J., Clagett GP et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation1996;94:3026-49.
5.
Rose GAThe diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull Wld Hlth Org1962;27:645-58.
6.
Rose GAPredicting coronary heart disease from minor symptoms and electrocardiogram findings. Brit J Prev Soc Med1971;25:94-6.
7.
Rose GA, McCartney P., Reid DDSelf administration of a questionnaire on chest pain and intermittent claudication . Brit J Prev Soc Med1977; 31:42-8.
8.
Sorlie PD, Cooper L., Schreiner PJ et al. Repeatability and validity of the Rose questionnaire for angina pectoris and the Atherosclerosis Risk in Communities Study. J Clin Epidemiol1996;49:719-25.
9.
LaCroix AZ, Haynes SG, Savage DD et al. Rose Questionnaire angina among United States black, white, and Mexican-American women and men. Prevalence and correlates from the Second National Hispanic Health and Nutrition Examination Surveys. Am J Epidemiol1989; 129:669-86.
10.
Cook DG, Shaper AG, MacFarlane PWUsing the WHO (Rose) angina questionnaire in cardiovascular epidemiology . Int J Epidemiol1989; 18:607-13.
11.
Balkau B., Vray M., Eschwege E.Epidemiology of peripheral arterial disease. J Cardiovasc Pharmacol1994;23(suppl 3):S8-S16.
12.
Hennekens CH , Eberlein K.A randomized trial of aspirin and- carotene among U.S. physicians. Prev Med1985 ;14:165-8.
13.
Manson JE, Buring JE, Satterfield S. et al. Baseline characteristics of participants in the Physicians' Health Study: a randomized trial of aspirin and -Carotene in U.S. physicians . Am J Prev Med1991;7:150-4.
14.
Henekens CH , Buring JEMethodological considerations in the design and conduct of randomized trials: The U.S. Physicians' Health Study . Controlled Clinical Trials1989;10:142S-150S.
15.
Hu FB, Stampfer MJ, Manson JE et al. Trends in the incidence of coronary heart disease and changes in the diet and lifestyle in women. N Engl J Med2000;343:530-7.
16.
Postiglione A., Cicerano U., Gallotta G. et al. Prevalence of peripheral arterial disease and related risk factors in elderly institutionalized subjects. Gerontology1992;38:330-7.
17.
Galllota G. , Iazzetta N., Milan G. et al. Prevalence of peripheral arterial disease in an elderly rural population of southern Italy . Gerontology1997;43:289-95.
18.
Ahmed JM, Hong MK, Mehran R. et al. Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: immediate and one-year clinical outcomes. JACC2000;35:1560-8.
19.
The Dutch TIA Trial study Group.A comparison of two doses of aspirin (30mg vs. 283mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med1991;325:1261-6.
20.
Frye RL, Kronmal R., Schaff HV et al. Stroke in coronary artery bypass graft surgery: an analysis of the CASS Experience. Int J Cardiol1992 ; 36:213-21.
21.
Nicoletti A. , Sofia V., Giuffrida S. et al. Prevalence of stroke: a door-to-door survey in rural Bolivia. Stroke2000;31:882-5.
22.
Singh M., Rihal CS, Berger PB et al. Improving outcomes over time of percutaneous coronary interventions in unstable angina. JACC2000;36:674-8.
23.
Levine GN, Mann DLPrimary Care Provider's Guide to Cardiology. Philadelphia, PA: Lippincott, Williams and Wilkins Publishers, 2000;57.
24.
Campeau L.Grading of angina pectoris (letter). Circulation1975;54: 522-3.
25.
Yarnell JW, Baker IA, Sweetnam PM et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation1991;83:836-44.
26.
Rose GA, Ahmeteli M., Checcacci L. et al. Ischemic heart disease in middle-aged men. Bull Wld Hlth Org1968;38:885-95.
27.
Criqui MH, Fronek A., Klauber MR et al. The sensitivity, specificity and predictive value of the traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation1985;71:516-22.
28.
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol1989;129:687-95.
29.
Landis R., Koch G.The measurement of observer agreement for categorical data. Biometrics1977:33:159-74.
30.
Donner A., Eliasziw M.A goodness-of-fit approach to inference procedures for R the kappa statistic: confidence interval construction, significance-testing and sample size estimation . Stat Med1991;11:1511-19.
